We employ our proprietary Transported Prodrug™ technology to develop our product candidates and focus our research and drug development efforts on medical conditions where we believe there is an unmet need.

We currently have three development-stage product candidates that are being evaluated as potential treatments for neuropathic pain, spasticity and Parkinson’s disease. We hold composition-of-matter patents on these product candidates as well as patents or patent applications for formulations and methods of synthesis and use.

Our current portfolio of proprietary product candidates includes the following: